IMURAN

This brand name is authorized in Australia, Brazil, Canada, Cyprus, Ecuador, Estonia, Hong Kong, Croatia, Ireland, Israel, Japan, Lithuania, Malta, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, Turkey, United Kingdom, United States, South Africa

Active ingredients

The drug IMURAN contains one active pharmaceutical ingredient (API):

1 Azathioprine UNII MRK240IY2L - AZATHIOPRINE

Azathioprine is a pro-drug of 6-mercaptopurine (6-MP). 6-MP is inactive but acts as a purine antagonist and requires cellular uptake and intracellular anabolism to thioguanine nucleotides (TGNs) for immunosuppression. The TGNs and other metabolites (e.g. 6-methyl-mecaptopurine ribonucleotides) inhibit de novo purine synthesis and purine nucleotide interconversions. Read about Azathioprine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
IMURAN Tablet	Medicines & Healthcare Products Regulatory Agency (GB)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L04AX01	Azathioprine	L Antineoplastic and immunomodulating agents → L04 Immunosuppressants → L04A Immunosuppressants → L04AX Other immunosuppressants
Discover more medicines within L04AX01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 2687K, 2688L
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 505612040035714, 505613110039803
Country: CA	Health Products and Food Branch	Identifier(s): 00004596, 02244895
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 29909-07-11
Country: EE	Ravimiamet	Identifier(s): 1004500, 1678158, 1865099
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 20186, 20202, 27698, 381404
Country: HK	Department of Health Drug Office	Identifier(s): 03804, 30975
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-628872163
Country: IE	Health Products Regulatory Authority	Identifier(s): 28762, 28847, 28894, 84612, 84625, 84638, 84662
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 1107, 2457
Country: JP	医薬品医療機器総合機構	Identifier(s): 3999005F1059
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1000951, 1085691, 1085796
Country: MT	Medicines Authority	Identifier(s): AA565/76001
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 69062
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 5681
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 16562, 337, 338
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100030481, 100030498
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W60846001
Country: SG	Health Sciences Authority	Identifier(s): 02082P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699874080090, 8699874080106
Country: US	FDA, National Drug Code	Identifier(s): 54766-590
Country: ZA	Health Products Regulatory Authority	Identifier(s): D/26/98